A detailed history of Ameriprise Financial Inc transactions in Avita Medical, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 44,324 shares of RCEL stock, worth $508,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,324
Previous 43,654 1.53%
Holding current value
$508,839
Previous $345,000 37.68%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.72 - $10.87 $5,172 - $7,282
670 Added 1.53%
44,324 $475,000
Q2 2024

Aug 14, 2024

SELL
$7.92 - $15.55 $64,650 - $126,934
-8,163 Reduced 15.75%
43,654 $345,000
Q1 2024

May 15, 2024

SELL
$12.56 - $18.31 $588,624 - $858,098
-46,865 Reduced 47.49%
51,817 $830,000
Q4 2023

Feb 14, 2024

SELL
$9.29 - $14.57 $144,589 - $226,767
-15,564 Reduced 13.62%
98,682 $1.35 Million
Q3 2023

Nov 14, 2023

SELL
$13.84 - $20.79 $3,543 - $5,322
-256 Reduced 0.22%
114,246 $1.67 Million
Q2 2023

Aug 14, 2023

SELL
$10.7 - $17.48 $183,044 - $299,030
-17,107 Reduced 13.0%
114,502 $1.95 Million
Q1 2023

May 15, 2023

SELL
$6.45 - $14.48 $105,412 - $236,646
-16,343 Reduced 11.05%
131,609 $1.84 Million
Q4 2022

Feb 14, 2023

SELL
$4.53 - $7.55 $7,859 - $13,099
-1,735 Reduced 1.16%
147,952 $976,000
Q3 2022

Nov 14, 2022

SELL
$4.97 - $7.89 $21,221 - $33,690
-4,270 Reduced 2.77%
149,687 $790,000
Q2 2022

Aug 15, 2022

BUY
$4.6 - $8.82 $194,326 - $372,600
42,245 Added 37.82%
153,957 $731,000
Q1 2022

May 16, 2022

BUY
$6.96 - $12.15 $777,515 - $1.36 Million
111,712 New
111,712 $947,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $287M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.